Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Botha

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
Antiviral Therapy|October 16, 2014
Efavirenz dosing: influence of drug metabolizing enzyme polymorphisms and concurrent tuberculosis treatmentTanuja N Gengiah, Julia H Botha, Nonhlanhla Yende-Zuma, et al.
Seminars in Oncology|June 12, 2025
Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy responseCarla Eksteen, Johann Riedemann, Frederick H van der Merwe, et al.
Journal of Health Psychology|November 25, 2011
Biopsychosocial determinants of self-management in culturally diverse South african patients with essential hypertensionKarel F H Botha, Wynand F Du Plessis, Johannes M Van Rooyen, et al.
Magnetic Resonance in Chemistry : MRC|April 5, 2008
Synthesis, complete 1H and 13C NMR assignment and crystal structure of novel epoxide derivatives of cytochalasin BPieter S Steyn, Jaco C Breytenbach, Jeanne H Botha, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 22, 2015
The Vaccine and Cervical Cancer Screen project 2 (VACCS 2): Linking cervical cancer screening to a two-dose HPV vaccination schedule in the South-West District of Tshwane, Gauteng, South AfricaL C Snyman, G Dreyer, C Visser, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 6, 2015
The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South AfricaLeon C Snyman, Greta Dreyer, Matthys H Botha, et al.
BMC Women'S Health|January 9, 2019
Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesionsJennifer Moodley, Deborah Constant, Matthys H Botha, et al.
Gynecologic Oncology|September 9, 2018
Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohortHannah M Simonds, Matthys H Botha, Alfred I Neugut, et al.
Plastic and Reconstructive Surgery|February 3, 2009
Negative-pressure wound therapy II: negative-pressure wound therapy and increased perfusion. Just an illusion?Nicolas Kairinos, Anda M Voogd, Pieter H Botha, et al.
South African Family Practice : Official Journal of the South African Academy of Family Practice/Primary Care|May 6, 2024
Sociodemographics, behaviour and knowledge of first South African HPV-vaccine recipientsRobyn A Adams, Cathy Visser, Greta Dreyer, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Antiviral Therapy|October 16, 2014
Efavirenz dosing: influence of drug metabolizing enzyme polymorphisms and concurrent tuberculosis treatmentTanuja N Gengiah, Julia H Botha, Nonhlanhla Yende-Zuma, et al.
Seminars in Oncology|June 12, 2025
Advancing personalized medicine in LMICs: Predictive indicators for cervical cancer immunotherapy responseCarla Eksteen, Johann Riedemann, Frederick H van der Merwe, et al.
Journal of Health Psychology|November 25, 2011
Biopsychosocial determinants of self-management in culturally diverse South african patients with essential hypertensionKarel F H Botha, Wynand F Du Plessis, Johannes M Van Rooyen, et al.
Magnetic Resonance in Chemistry : MRC|April 5, 2008
Synthesis, complete 1H and 13C NMR assignment and crystal structure of novel epoxide derivatives of cytochalasin BPieter S Steyn, Jaco C Breytenbach, Jeanne H Botha, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 22, 2015
The Vaccine and Cervical Cancer Screen project 2 (VACCS 2): Linking cervical cancer screening to a two-dose HPV vaccination schedule in the South-West District of Tshwane, Gauteng, South AfricaL C Snyman, G Dreyer, C Visser, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|August 6, 2015
The Vaccine and Cervical Cancer Screen (VACCS) project: Linking cervical cancer screening to HPV vaccination in the South-West District of Tshwane, Gauteng, South AfricaLeon C Snyman, Greta Dreyer, Matthys H Botha, et al.
BMC Women'S Health|January 9, 2019
Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesionsJennifer Moodley, Deborah Constant, Matthys H Botha, et al.
Gynecologic Oncology|September 9, 2018
Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohortHannah M Simonds, Matthys H Botha, Alfred I Neugut, et al.
Plastic and Reconstructive Surgery|February 3, 2009
Negative-pressure wound therapy II: negative-pressure wound therapy and increased perfusion. Just an illusion?Nicolas Kairinos, Anda M Voogd, Pieter H Botha, et al.
South African Family Practice : Official Journal of the South African Academy of Family Practice/Primary Care|May 6, 2024
Sociodemographics, behaviour and knowledge of first South African HPV-vaccine recipientsRobyn A Adams, Cathy Visser, Greta Dreyer, et al.
Pageof 10